The mortality due to malignant neoplasms among Canadian women is projected to decline steadily from 2024 to 2028. In 2023, the rate stood at approximately 163.5 per hundred thousand women. The forecast indicates an annual decrease, with the rate decreasing by an average of 2-3% year-on-year. Over the last two years from 2024, this reduction trend precisely begins with 161.1 in 2024 to 152.6 in 2028. The compound annual growth rate (CAGR) from 2023 to 2028 suggests a consistent downtrend, reinforcing the positive direction in mortality management.
Future trends to monitor include advancements in medical technology and research, shifts in health policies, and public health initiatives that could further drive this trend. Additionally, variations in demographics and lifestyle factors such as smoking cessation and diet should be closely observed as they could significantly impact these projections.
